Novo Nordisk announced on Thursday that a key European Medicines Agency committee has backed a label update for weight-loss ...

Nigerian PhD student, Sue Agazie, received a tuition refund from Newcastle University after distress over unpaid fees while ...

Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart ...

Many biotechnology companies don't have approved products on the market, so they don't generate reliable revenue. From time ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and ...